APA (7th ed.) Citation

RP, B., RM, C., B, G., F, S., & M, G. (2021). The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors. BMC cancer, 21(1), 969. https://doi.org/10.1186/s12885-021-08702-x

Chicago Style (17th ed.) Citation

RP, Bissonnette, Cesario RM, Goodenow B, Shojaei F, and Gillings M. "The Epigenetic Immunomodulator, HBI-8000, Enhances the Response and Reverses Resistance to Checkpoint Inhibitors." BMC Cancer 21, no. 1 (2021): 969. https://doi.org/10.1186/s12885-021-08702-x.

MLA (9th ed.) Citation

RP, Bissonnette, et al. "The Epigenetic Immunomodulator, HBI-8000, Enhances the Response and Reverses Resistance to Checkpoint Inhibitors." BMC Cancer, vol. 21, no. 1, 2021, p. 969, https://doi.org/10.1186/s12885-021-08702-x.